Schroder Investment Management Group
WX

Schroder Investment Management Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Schroder Investment Management Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,323,070
Closed -$273M – 1295
2015
Q3 		$273M Sell
6,323,070
-33,531
-0.5% -$1.41M 0.58% 32
2015
Q2 		$263M Sell
6,356,601
-301,499
-5% -$12.7M 0.52% 37
2015
Q1 		$251M Buy
6,658,100
+110,797
+2% +$4.27M 0.49% 39
2014
Q4 		$220M Buy
6,547,303
+651,491
+11% +$23M 0.43% 53
2014
Q3 		$206M Buy
5,895,812
+927,227
+19% +$31.8M 0.28% 73
2014
Q2 		$163M Sell
4,968,585
-172,353
-3% -$5.9M 0.2% 95
2014
Q1 		$189M Buy
5,140,938
+48,802
+1% +$1.79M 0.21% 89
2013
Q4 		$195M Sell
5,092,136
-655,076
-11% -$20.7M 0.24% 76
2013
Q3 		$157M Sell
5,747,212
-360,453
-6% -$8.54M 0.38% 60
2013
Q2 		$128M Buy
+6,107,665
New +$119M 0.34% 70

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Schroder Investment Management Group's WX Position: Q4 2015 in Review

Schroder Investment Management Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 6,323,070 shares — an estimated $273M sold.

Schroder Investment Management Group first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $273M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Schroder Investment Management Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Schroder Investment Management Group sold 6,323,070 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $273M.
  • Schroder Investment Management Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Schroder Investment Management Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $273M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Schroder Investment Management Group's 13F filing for Q4 2015, filed 10 Feb 2016.